Trials / Completed
CompletedNCT01819649
Selenium in the Prevention of Cancer
Prevention of Cancer by Intervention With Selenium - A Pilot Study in a Danish Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 491 (actual)
- Sponsor
- Odense University Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years – 74 Years
- Healthy volunteers
- Accepted
Summary
This is a pilot study proceeding an intended international trial. Hypothesis: Daily intake of selenium supplementation in the form of selenium-enriched yeast tablets will reduce the risk of cancer in healthy individuals. Objective: The objective of this pilot study was to assess the viability of a full scale randomised trial. AMENDMENT TO STUDY OBJECTIVE: Mortality analysis during intervention and follow-up as specified in the sections concerning study design and outcome measures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | SelenoPRECISE selenium-enriched yeast tablet, Pharma Nord Denmark A/S |
Timeline
- Start date
- 1998-11-01
- Primary completion
- 2004-06-01
- Completion
- 2004-06-01
- First posted
- 2013-03-27
- Last updated
- 2017-09-14
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01819649. Inclusion in this directory is not an endorsement.